Enalapril
Epaned, Vasotec (enalapril) is a small molecule pharmaceutical. Enalapril was first approved as Epaned on 1985-12-24. It is used to treat bartter syndrome, diabetic nephropathies, edema, heart failure, and left ventricular dysfunction amongst others in the USA. The pharmaceutical is active against angiotensin-converting enzyme. Vasotec's patents are valid until 2036-03-25 (FDA).
| Trade Name | Epaned, Vasotec |
|---|---|
| Common Name | Enalapril |
| Indication | bartter syndrome, diabetic nephropathies, edema, heart failure, left ventricular dysfunction, malignant hypertension, rheumatoid arthritis |
| Drug Class | Narcotic agonists/antagonists (normorphine type); antihypertensives (ACE inhibitors) |
